News Snapshot:
Bayer invests €1.3B in next-gen healthcare PHARMACEUTICAL company Bayer AG announced on April 1 that it is investing more than €1.3 billion over the next three years in tackling “the challenges facing humanity” — including cancer, neurodegenerative disease, and agriculture’s environmental impact — through Leaps by Bayer , its impact investment unit. “We stand at the dawn of a new age of innovation in the Life Sciences,” said Werner Baumann, chairman of the board of management of Bayer AG, in a statement. Added Jürgen Eckhardt, head of Leaps by Bayer: “We will be able to continue on our successful path...
